EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Research Progress on Natural Products Alleviating Liver Inflammation and Fibrosis via NF‐κB Pathway

Xiaoying Li, Saifei Li, Ningning Li iD

Chemistry & Biodiversity · 2025

DOI: 10.1002/cbdv.202402248 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Chemistry & Biodiversity, 2025. Verfasst von Xiaoying Li und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Henan Medical College, Zhengzhou, Henan, China. Hauptthemen laut MEDLINE: NF-kappa B, Biological Products, Liver Cirrhosis, Inflammation. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 113 Literaturangaben. Gefördert von: Key Technologies R&D Program of Henan Province, Key Scientific Research Project for University of Henan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Liver fibrosis is a key pathological process in chronic liver diseases, regulated by various cytokines and signaling pathways. Among these, the nuclear factor kappa‐light‐chain‐enhancer of activated B cells (NF‐κB) signaling pathway plays a significant role in the initiation and progression of liver fibrosis. Recently, natural products have garnered attention as potential anti‐fibrotic agents. This review highlights recent studies on how natural products, including flavonoids, terpenoids, polysaccharides, phenols, alkaloids, quinones, phenylpropanoids, steroids, and nitrogen compounds, mitigate liver fibrosis by modulating the NF‐κB signaling pathway. Specifically, it examines how these natural products influence NF‐κB activation, nuclear translocation, and downstream signaling, thereby inhibiting inflammatory responses, reducing apoptosis, and regulating hepatic stellate cell (HSC) activity, ultimately achieving therapeutic effects against liver fibrosis. A deeper understanding of the mechanisms by which natural products regulate the NF‐κB signaling pathway can provide crucial theoretical foundations and valuable insights for the development of novel anti‐fibrotic drugs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NF-kappa BBiological ProductsLiver CirrhosisInflammationHumansSignal TransductionAnimalsHepatic Stellate Cells

Stichwörter der Autor:innen

liver fibrosisnatural productsnuclear factor kappa‐light‐chain‐enhancer of activated B cells (NF‐κB) pathway

Substanzen

NF-kappa BBiological Products

Autor:innen und Institutionen

  • Department of Pathology, Henan Medical College, Zhengzhou, Henan, China.
  • Department of Pharmacy, Henan Medical College, Zhengzhou, Henan, China.

ORCID-Profile: Ningning Li

Förderung

  • Key Technologies R&D Program of Henan Province
  • Key Scientific Research Project for University of Henan Province

Zitieren

APA

Li, X., Li, S., & Li, N. (2025). Research Progress on Natural Products Alleviating Liver Inflammation and Fibrosis via NF‐κB Pathway. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202402248

Vancouver

Li X, Li S, Li N. Research Progress on Natural Products Alleviating Liver Inflammation and Fibrosis via NF‐κB Pathway. Chemistry & Biodiversity. 2025. doi:10.1002/cbdv.202402248

BibTeX
@article{Li2025,
  author = {Li, Xiaoying and Li, Saifei and Li, Ningning},
  title = {Research Progress on Natural Products Alleviating Liver Inflammation and Fibrosis via NF‐κB Pathway},
  journal = {Chemistry & Biodiversity},
  year = {2025},
  doi = {10.1002/cbdv.202402248}
}
Kostenlos starten →